These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 9741698

  • 21. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y, Liu XQ, Rall SC, Mahley RW.
    J Biol Chem; 1998 Jul 10; 273(28):17483-90. PubMed ID: 9651338
    [Abstract] [Full Text] [Related]

  • 22. In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE.
    van Dijk KW, van Vlijmen BJ, van't Hof HB, van der Zee A, Santamarina-Fojo S, van Berkel TJ, Havekes LM, Hofker MH.
    J Lipid Res; 1999 Feb 10; 40(2):336-44. PubMed ID: 9925664
    [Abstract] [Full Text] [Related]

  • 23. Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase.
    Hendriks WL, van der Sman-de Beer F, van Vlijmen BJ, van Vark LC, Hofker MH, Havekes LM.
    Arterioscler Thromb Vasc Biol; 1997 Mar 10; 17(3):498-504. PubMed ID: 9102168
    [Abstract] [Full Text] [Related]

  • 24. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A, Gibson JC, Paterniti JR, Kakis G, Little A, Ginsberg HN, Brown WV.
    J Clin Invest; 1985 Feb 10; 75(2):710-21. PubMed ID: 3973025
    [Abstract] [Full Text] [Related]

  • 25. Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.
    Ćwiklińska A, Cackowska M, Wieczorek E, Król E, Kowalski R, Kuchta A, Kortas-Stempak B, Gliwińska A, Dąbkowski K, Zielińska J, Dębska-Ślizień A, Jankowski M.
    Kidney Blood Press Res; 2018 Feb 10; 43(3):970-978. PubMed ID: 29913451
    [Abstract] [Full Text] [Related]

  • 26. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P, Wang CS, McConathy WJ, Weiser D, Downs D.
    Arch Biochem Biophys; 1986 Jan 10; 244(1):226-37. PubMed ID: 3080947
    [Abstract] [Full Text] [Related]

  • 27. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH, Segrest JP, Franklin F.
    Atherosclerosis; 1998 Dec 10; 141(2):209-25. PubMed ID: 9862170
    [Abstract] [Full Text] [Related]

  • 28. A change in apolipoprotein B expression is required for the binding of apolipoprotein E to very low density lipoprotein.
    Ishikawa Y, Fielding CJ, Fielding PE.
    J Biol Chem; 1988 Feb 25; 263(6):2744-9. PubMed ID: 2449429
    [Abstract] [Full Text] [Related]

  • 29. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.
    Huff MW, Miller DB, Wolfe BM, Connelly PW, Sawyez CG.
    J Lipid Res; 1997 Jul 25; 38(7):1318-33. PubMed ID: 9254059
    [Abstract] [Full Text] [Related]

  • 30. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL.
    J Biol Chem; 1990 Mar 15; 265(8):4266-72. PubMed ID: 2307668
    [Abstract] [Full Text] [Related]

  • 31. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
    Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T.
    J Biol Chem; 1995 Jun 30; 270(26):15747-54. PubMed ID: 7797576
    [Abstract] [Full Text] [Related]

  • 32. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.
    Westerterp M, de Haan W, Berbée JF, Havekes LM, Rensen PC.
    J Lipid Res; 2006 Jun 30; 47(6):1203-11. PubMed ID: 16537968
    [Abstract] [Full Text] [Related]

  • 33. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
    de Man FH, de Beer F, van de Laarse A, Smelt AH, Leuven JA, Havekes LM.
    Atherosclerosis; 1998 Feb 30; 136(2):255-62. PubMed ID: 9543096
    [Abstract] [Full Text] [Related]

  • 34. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.
    Schreier L, Berg G, Zago V, Gonzalez AI, Wikinski R.
    Nutr Metab Cardiovasc Dis; 2002 Feb 30; 12(1):13-8. PubMed ID: 12125224
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
    Di Filippo M, Marçais C, Charrière S, Marmontel O, Broyer M, Delay M, Merlin M, Nollace A, Valéro R, Lagarde M, Pruneta-Deloche V, Moulin P, Sassolas A.
    PLoS One; 2014 Feb 30; 9(5):e96482. PubMed ID: 24788417
    [Abstract] [Full Text] [Related]

  • 37. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center.
    Salinelli S, Lo JY, Mims MP, Zsigmond E, Smith LC, Chan L.
    J Biol Chem; 1996 Sep 06; 271(36):21906-13. PubMed ID: 8702993
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lipolysis-induced degradation of apolipoproteins B and E of human very low density lipoproteins.
    Chung BH, Im JH, Bowdon HR.
    J Biol Chem; 1986 Feb 25; 261(6):2960-7. PubMed ID: 3949755
    [Abstract] [Full Text] [Related]

  • 40. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
    Grosskopf I, Baroukh N, Lee SJ, Kamari Y, Harats D, Rubin EM, Pennacchio LA, Cooper AD.
    Arterioscler Thromb Vasc Biol; 2005 Dec 25; 25(12):2573-9. PubMed ID: 16166565
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.